TY  - GEN
AU  - Yu,Evan Y
AU  - Gulati,Roman
AU  - Telesca,Donatello
AU  - Jiang,Peter
AU  - Tam,Stephen
AU  - Russell,Kenneth J
AU  - Nelson,Peter S
AU  - Etzioni,Ruth D
AU  - Higano,Celestia S
TI  - Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation
SN  - 1527-7755
PY  - 2010///0721
KW  - Aged
KW  - Aged, 80 and over
KW  - Analysis of Variance
KW  - Androgen Antagonists
KW  - administration & dosage
KW  - Antineoplastic Agents, Hormonal
KW  - Brachytherapy
KW  - methods
KW  - Castration
KW  - Cause of Death
KW  - Chemotherapy, Adjuvant
KW  - Confidence Intervals
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Flutamide
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunohistochemistry
KW  - Kaplan-Meier Estimate
KW  - Leuprolide
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Probability
KW  - Prospective Studies
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatectomy
KW  - Prostatic Neoplasms
KW  - mortality
KW  - Risk Assessment
KW  - Salvage Therapy
KW  - Survival Analysis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2009.25.1330
ER  -